Ozyme
Ozyme is a French laboratory products distributor serving research laboratories in France since 1984, specializing in cell biology, immunology, and molecular biology reagents, equipment, and consumables sourced from major international brands.
- Company typePrivate
- Founded1984
- HeadquartersSaint-cyr-l'ecole, France
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Ozyme does
Ozyme SAS is a French specialty distributor of laboratory products for research, operating since 1984 from Saint-Cyr-l'École near Paris. The company aggregates a catalog of more than 10,000 SKUs across cell biology, immunology, and molecular biology, sourced from roughly 20 international manufacturers including Corning (cell culture), Cell Signaling Technology, Bethyl Laboratories, Jackson ImmunoResearch, and Leinco Technologies (antibodies), Lexogen, Navinci, Codex DNA and Bio-Works (molecular biology), as well as newer 2025-vintage partners Standard BioTools (Biomark X9), ACEPIX (IHC/spatial biology), AOPIA Biosciences (NANOEX extracellular vesicle system), and Illumina (MiSeq i100 NGS sequencers, partnership announced April 2026). In September 2025 Ozyme launched its first proprietary private-label line, OWIBIO, a range of bioreagents for PCR/qPCR/West blot co-developed with parent Dominique Dutscher. Earlier proprietary or featured items include the EVE PLUS automatic cell counter, EXTRANSFECTION electroporation pipette system, and refurbished equipment trade-ins.
The business is sales-led, combining an e-commerce storefront (yris.ozyme.fr), a direct sales team, and an inside-sales/customer-service desk handling availability, pricing, quotes, and French public procurement. Roughly half of the ~40-employee team hold 3rd-cycle university or engineering-school scientific credentials, and the company claims 80% of technical questions are answered without delay and 24-hour express delivery for in-stock items. Revenue is generated through unit, kit, and equipment sales with quote-based pricing; no subscription model is offered. Ozyme was acquired by Dominique Dutscher, a French life sciences distribution group, in May 2023, and continues to operate under the Ozyme brand serving research laboratories exclusively in France.
Customer profiles and named logos are not disclosed in available materials; based on product mix (antibodies, NGS reagents, qPCR systems, cell culture, IHC, EV isolation) and French-language public-procurement handling, end users are predominantly academic, hospital, biotech, and CRO research laboratories. Marketing reaches these buyers via a monthly newsletter (INFOZYME), technical letters (TechOzyme), social channels (LinkedIn, Facebook, Instagram, YouTube), scientific congresses, webinars, and product video tutorials. No AI, machine learning, public APIs, mobile apps, patents, or external funding rounds are disclosed, and revenue is not publicly reported.
Ozyme firmographics
Firmographics- Name
- Ozyme
- Legal name
- OZYME SAS
- Website
- https://yris.ozyme.fr
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Ozyme is a French laboratory products distributor serving research laboratories in France since 1984, specializing in cell biology, immunology, and molecular biology reagents, equipment, and consumables sourced from major international brands.
- Ownership category
- akta.pro rank
Where Ozyme is headquartered
LocationHeadquarters
- HQ city
- Saint-cyr-l'ecole
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Ozyme business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Laboratory Products Distribution: Revenue generated from distributing laboratory products including antibodies, molecular biology reagents, cell culture supplies, consumables, and laboratory equipment from various brand partners to research laboratories in France.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Various laboratory products with unit-based pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Ozyme product offering
Product offeringCore offering
Ozyme is a specialty distributor of laboratory products for life sciences research in France, supplying research laboratories with antibodies, molecular biology reagents, cell culture consumables, and laboratory equipment sourced from leading manufacturers such as Cell Signaling Technology, Illumina, Corning, and Standard BioTools. The company offers its own OWIBIO molecular biology bioreagent line and provides technical support, 24-hour express delivery, equipment installation, and maintenance services alongside product sales.
Product overview
Ozyme is a specialized laboratory products distributor serving the French research market since 1984, offering a comprehensive portfolio of products across cell biology, immunology, and molecular biology. The company operates as a multi-brand distributor, aggregating products from major international manufacturers (Cell Signaling Technology, Illumina, Standard BioTools, Corning, and others) alongside proprietary offerings. Key branded products include the OWIBIO molecular biology reagent line, NANOEX™ automated extracellular vesicle purification system, EVE™ PLUS automatic cell counters, EXTRANSFECTION™ electroporation devices, and PhosphoPlus® Antibody Duets from Cell Signaling Technology. Ozyme also distributes Illumina sequencing systems (MiSeq i100 series), Standard BioTools' Biomark X9 microfluidic qPCR platform, and ACEPIX tissue analysis solutions. The company provides equipment installation and support services alongside product sales, targeting research laboratories in France with a team of technically-trained scientific staff.
Differentiator
Problem solved
Functional benefit
Brands
- OWIBIO: A brand of bioréactifs (bioreagents) for molecular biology applications including PCR (routine, hot start, high fidelity), RT & qPCR, electrophoresis, and Western blot. Developed in collaboration with Dutscher.
Products and services
- Antibodies (Primary and Secondary)
- Molecular Biology Reagents
- Cell Culture and Analysis Products
- Laboratory Equipment
- OWIBIO Bioréactifs Molecular Biology Range
- NANOEX Extracellular Vesicle Purification System
- EVE PLUS Automatic Cell Counter
- EXTRANSFECTION Electroporation System
- PhosphoPlus Antibody Duets
- Illumina MiSeq i100 and i100 Plus Sequencers
Quantifiable outcome
- Technical service answering 80% of questions without delay
- +1 more outcomes
Companies that use Ozyme
Customer profileSegments1 record
Ideal customer profiles1 record
Ozyme technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Ozyme partnerships and signals
Strategic signalPartnerships
16 partnerships are on record, tiered core.
- IlluminacoreNew collaboration between Ozyme and Illumina, world leader in DNA sequencing (NGS). This collaboration aims to combine Ozyme's expertise and Illumina's advanced sequencing technologies to facilitate laboratories' access to sequencing solutions. The common goal is to make genome study simpler and more accessible for all.
- OWIBIO (Dutscher)coreLaunch of OWIBIO bioréactifs product line for molecular biology applications. Result of tight scientific collaboration between Ozyme and Dutscher, offering reliable and accessible solutions at the right price combining scientific expertise and field proximity.
- AOPIA BiosciencescorePartnership with AOPIA Biosciences, expert in innovative extracellular vesicle (EV) purification technologies used in biomedical research and cosmetics. This collaboration allows Ozyme to offer cutting-edge solutions for EV isolation, meeting growing needs for quality, reproducibility, and performance.
- Standard BioToolscorePartnership enriching Ozyme's genomics portfolio with Standard BioTools' Biomark X9 platform, a high-throughput automated microfluidic qPCR solution. This collaboration brings cutting-edge technology to multiply analysis capabilities while optimizing sample and reagent consumption.
- ACEPIX BiosciencescorePartnership strengthening Ozyme's immunohistochemistry (IHC) and spatial biology offerings with ACEPIX's advanced tissue analysis solutions. This collaboration enriches and perfectly complements their IHC portfolio with innovative technologies for improved precision, reproducibility, and efficiency.
- Dominique DutschercoreDutscher group acquisition of Ozyme in France, strengthening their presence in Life Sciences sector in France.
- Leinco TechnologiescorePartnership expanding portfolio with Leinco Technologies' solutions, recognized specialist in antibodies, recombinant proteins, and research reagents including functional in vivo antibodies. Strengthens cell biology and immunology offerings.
- Bio-WorkscorePartnership with ISO 9001 certified Swedish company developing protein purification resins for research laboratories and large-scale bioproduction. WorkBeads™ agarose-based next-generation resins for purifying histidine-tagged proteins, antibodies, peptides, and other biomolecules.
- SlingshotcorePartnership adding Slingshot's synthetic cell solutions for flow cytometry calibration and compensation. Products include SpectraCom® for spectral/conventional cytometry, ViaComp® for viability markers, FlowCyte® for instrument calibration, and TruCytes® with biomarker-incorporating synthetic cells.
- NavincicorePartnership adding Navinci's Proximity Ligation platform technology for analyzing and quantifying proteins at molecular level in natural cellular environment. Applications include immuno-profiling, signaling, drug screening, and biomarker discovery.
- LexogencorePartnership with Austrian company specializing in transcriptome profiling solutions and NGS data analysis. Key technologies include QuantSeq 3' mRNA-Seq Library Prep, RiboCop rRNA Depletion, and CORALL Total RNA-Seq Library Prep.
- Codex DNAcorePartnership adding Codex DNA's synthetic gene production solutions including Gibson Assembly® kits (co-founded by Dan Gibson, inventor of Gibson cloning technology) and Vmax™ competent cells for protein production in bacteria.
- Jackson Immuno Research (JIR)coreJIR, American company with 35+ years specializing in secondary antibody production and purification. Products include secondary antibodies conjugated with fluorophores, enzymes (HRP, PA), or gold beads for IF, FC, IHC, ELISA, WB, and electron microscopy applications.
- CorningcorePartnership with Corning for cell culture products, leveraging 160 years of innovation and excellence. Complete portfolio of high-quality cell culture media and consumables from a recognized R&D expert in life sciences.
- Azure BiosystemscorePartnership for gel and Western blot imagers and scanners. Products include cSeries imagers for chemiluminescence and fluorescence detection, and Sapphire™ scanners combining phosphorimaging, fluorescence, and chemiluminescence capabilities.
- Bethyl LaboratoriescorePartnership adding Bethyl Laboratories' antibody catalog with over 19,000 antibody references for WB, IP, ELISA, and IHC in cancer, cardiovascular, cell biology, immunology, neurobiology, and signal transduction fields.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
Ozyme competitors and assessment
Company assessmentDirect peers
- Tebu-bio: European distributor of life science research reagents and instruments, active in France through Tebu-bio SAS. Overlaps with Ozyme in antibody, cell biology, and molecular biology distribution to French and Benelux research labs.
- Carl Roth: German specialty distributor of chemicals, reagents, and consumables for life science and analytical laboratories across Europe. Comparable as a multi-brand European lab products specialist with strong own-label portfolio (Roti, Rotipuran) serving research customers.
- Dominique Dutscher: French life sciences distribution group and parent of Ozyme since May 2023. Operates an overlapping multi-brand catalog of laboratory consumables, reagents, and equipment across France with comparable customer base (research labs, biotech, pharma). Most directly comparable peer given the ownership and product overlap.
Broad incumbents
- Abcam (Danaher): Global antibody specialist (now part of Danaher) with a 100,000+ product catalog and direct e-commerce/distribution in France. Direct overlap with Ozyme's primary and secondary antibody business, with primary antibodies representing a core Ozyme category.
- Bio-Techne: Global life sciences company with deep catalog of reagents (antibodies, proteins, ELISA kits, cell/gene therapy tools) and direct sales across Europe, including France. Competes with Ozyme in antibody and protein reagent distribution but at much larger scale and with proprietary products (R&D Systems, Novus, Tocris).
- Merck Life Science (MilliporeSigma): Global life science arm of Merck KGaA distributing reagents, antibodies, lab consumables, and bioprocessing products with significant direct presence in France. Overlaps with Ozyme's molecular biology, cell culture, and antibody offerings but operates at much larger scale with proprietary product lines.
- Thermo Fisher Scientific: Largest global life sciences tools and reagents provider with direct sales and distribution of antibodies, molecular biology reagents, cell culture, and lab equipment across France. Competes with Ozyme across nearly every category but as part of a much broader portfolio.
- Avantor (VWR): Global laboratory products and services distributor (formerly VWR) serving research, pharma, and academic customers across Europe, including France. Comparable distribution model and customer base but vastly broader catalog spanning chemicals, consumables, equipment, and life sciences.
Regional players
- Clinisciences: French life sciences distributor of reagents, antibodies, and cell biology products for research and clinical markets. Comparable business model and customer base to Ozyme, focused on the French-speaking research community.
Emerging players
- Cell Signaling Technology (CST): US-based antibody and reagent developer that Ozyme distributes in France. Comparable as a specialized antibody supplier with strong presence in signaling pathway research; an upstream supplier to Ozyme but also a competitor when end users buy direct.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key highlights7 records
Customer concentration
Ozyme social profiles
Digital presenceOzyme financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ozyme leadership team
Management profileNumber of profiles
Ozyme funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ozyme M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ozyme
What does Ozyme do?
Ozyme is a specialty distributor of laboratory products for life sciences research in France, supplying research laboratories with antibodies, molecular biology reagents, cell culture consumables, and laboratory equipment sourced from leading manufacturers such as Cell Signaling Technology, Illumina, Corning, and Standard BioTools. The company offers its own OWIBIO molecular biology bioreagent line and provides technical support, 24-hour express delivery, equipment installation, and maintenance services alongside product sales.
Is Ozyme a public or private company?
Ozyme is a private company. It is classified as corporate owned and is currently operating.
When was Ozyme founded?
Ozyme was founded in 1984. It employs 11 to 50 people.
Where is Ozyme based?
Ozyme is headquartered in Saint-cyr-l'ecole, France, in the Europe region.
How does Ozyme make money?
One revenue line is on record: laboratory Products Distribution.
Who are Ozyme's main competitors?
Direct peers on record are Tebu-bio, Carl Roth and Dominique Dutscher. Broad incumbents are Abcam (Danaher), Bio-Techne, Merck Life Science (MilliporeSigma), Thermo Fisher Scientific and Avantor (VWR). Clinisciences is listed as a regional player. Cell Signaling Technology (CST) is listed as an emerging player.
Does Ozyme have an API?
No public API is recorded for Ozyme.